CSL spotlights developments in cell-based vaccine technology at Australian Research and Development briefing

Two Australian scientists have each been awarded an AUD$1.25 million, five-year, CSL Centenary Fellowship to further research into why so many people die from infection following stroke and how we might develop better vaccines against diseases such as tuberculosis.

CSL today announced an AUD$50,000 donation in support of Indonesian earthquake and tsunami relief efforts.

Thomson Reuters Includes the Global Biotechnology Leader in its 2018 Top 100 Global Diversity and Inclusion Index

$2.5 Million Funding Available to Australian Biomedical Researchers

CSL Limited today announced a revised profit outlook for
fiscal 2018.